Rifamycin SV

Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.

Cross Reference

Introduction

To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Rifamycin SV?

Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Rifamycin SV

MeSH term MeSH ID Detail
Diarrhea D003967 32 associated lipids
Pain D010146 64 associated lipids
Abscess D000038 13 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Osteomyelitis D010019 10 associated lipids
Alzheimer Disease D000544 76 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Anaphylaxis D000707 35 associated lipids
Per page 10 20 | Total 18

PubChem Associated disorders and diseases

What pathways are associated with Rifamycin SV

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Rifamycin SV?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Rifamycin SV?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

What genes are associated with Rifamycin SV?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Rifamycin SV

Download all related citations
Per page 10 20 50 100 | Total 175
Authors Title Published Journal PubMed Link
pmid:
Magnan A et al. Anaphylactic reaction to rifamycin SV: presence of specific IgE antibodies. 1999 J. Allergy Clin. Immunol. pmid:10329836
van Montfoort JE et al. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. 1999 J. Pharmacol. Exp. Ther. pmid:10381771
Courtois A et al. Inhibition of multidrug resistance-associated protein (MRP) activity by rifampicin in human multidrug-resistant lung tumor cells. 1999 Cancer Lett. pmid:10408915
Zhang W et al. Sequence analysis and expression of the aspartokinase and aspartate semialdehyde dehydrogenase operon from rifamycin SV-producing amycolatopsis mediterranei. 1999 Gene pmid:10521665
Stieger B et al. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. 2000 Gastroenterology pmid:10648470
Zhang W et al. Molecular analysis and heterologous expression of the gene encoding methylmalonyl-coenzyme A mutase from rifamycin SV-producing strain Amycolatopsis mediterranei U32. 1999 Appl. Biochem. Biotechnol. pmid:10813025
Zhang W et al. A novel transmembrane serine/threonine protein kinase gene from a rifamycin SV-producing amycolatopsis mediterranei U32. 2000 Eur. J. Biochem. pmid:10848993
Fattinger K et al. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2. 2000 Hepatology pmid:10869292
Murali Krishna PS et al. Effect of uracil on rifamycin SV production by Amycolatopsis mediterranei MV35R. 2000 Lett. Appl. Microbiol. pmid:10886619
Cui Y et al. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. 2001 J. Biol. Chem. pmid:11134001
van De Waterbeemd H et al. Property-based design: optimization of drug absorption and pharmacokinetics. 2001 J. Med. Chem. pmid:11311053
Noe J et al. Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. 2001 Hepatology pmid:11343252
Yang L et al. An eukaryotic-type serine/threonine protein kinase involved in the carbon source-dependent pigment biosynthesis in Amycolatopsis mediterranei U32. 2001 Biochem. Biophys. Res. Commun. pmid:11394886
Scala E et al. Multiple drug allergy syndrome: severe anaphylactic reaction due to topical rifamycin SV in a patient with hypersensitivity to ciprofloxacin. 2001 Int. J. Dermatol. pmid:11737462
Vavricka SR et al. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. 2002 Hepatology pmid:12085361
Wang W et al. Molecular and biochemical characterization of a novel two-component signal transduction system, amrA- amkA, involved in rifamycin SV production in Amycolatopsis mediterranei U32. 2002 Arch. Microbiol. pmid:12375106
Wang W et al. MoeA, an enzyme in the molybdopterin synthesis pathway, is required for rifamycin SV production in Amycolatopsis mediterranei U32. 2002 Appl. Microbiol. Biotechnol. pmid:12382055
Byrne JA et al. The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. 2002 Gastroenterology pmid:12404239
Krishna PS et al. Biosynthesis of rifamycin SV by Amycolatopsis mediterranei MTCC17 in solid cultures. 2003 Biotechnol. Appl. Biochem. pmid:12546705
Radossi P et al. Intra-articular rifamycin in haemophilic arthropathy. 2003 Haemophilia pmid:12558780
Wang EJ et al. Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. 2003 Pharm. Res. pmid:12739759
Kukiełka E and Cederbaum AI Stimulation of microsomal production of reactive oxygen intermediates by rifamycin SV: effect of ferric complexes and comparisons between NADPH and NADH. 1992 Arch. Biochem. Biophys. pmid:1329662
MARGALITH P and PAGANI H Rifomycin. XIII. Fermentation and production of rifomycin complex. 1961 Appl Microbiol pmid:13766660
MARGALITH P and PAGANI H Rifomycin. XIV. Production of rifomycin B. 1961 Appl Microbiol pmid:13766661
Mancuso G and Masarà N Contact urticaria and severe anaphylaxis from rifamycin SV. 1992 Contact Derm. pmid:1395622
SHILO M THE USE OF LEVAN-ENHANCED DERMAL INFECTIONS IN RABBITS IN THE STUDY OF IN VIVO ACTIVITY OF ANTIBIOTIC SUBSTANCES. 1964 Br J Exp Pathol pmid:14140754
THIEMANN JE et al. RIFAMYCIN. XXXIII. ISOLATION OF ACTINOPHAGES ACTIVE ON STREPTOMYCES MEDITERRANEI AND CHARACTERISTICS OF PHAGE-RESISTANT STRAINS. 1964 Appl Microbiol pmid:14167333
THIEMANN JE et al. RIFAMYCIN. XXXIV. PHYSICOCHEMICAL CHARACTERIZATION OF ACTINOPHAGES ACTIVE ON STREPTOMYCES MEDITERRANEI. 1964 Appl Microbiol pmid:14170965
KLUEPFEL D et al. METABOLISM OF BARBITAL BY STREPTOMYCES MEDITERRANEI. 1965 Appl Microbiol pmid:14339268
Eichler HG et al. Studies on the uptake of low molecular weight monomeric tris-galactosyl conjugates by the rat liver. 1992 Biochem. Pharmacol. pmid:1472076
Nettles RE et al. Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use. 2004 Clin. Infect. Dis. pmid:14986259
Wang W et al. A novel two-component system amrB-amkB involved in the regulation of central carbohydrate metabolism in rifamycin SV-producing Amycolatopsis mediterranei U32. 2004 Curr. Microbiol. pmid:15018097
Caruso I et al. Clinical improvement in ankylosing spondylitis with rifamycin SV infiltrations of peripheral joints. 1992 J. Int. Med. Res. pmid:1521673
Knight JL et al. Distance-restrained docking of rifampicin and rifamycin SV to RNA polymerase using systematic FRET measurements: developing benchmarks of model quality and reliability. 2005 Biophys. J. pmid:15542547
Chen C et al. Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. 2005 Drug Metab. Dispos. pmid:15616150
Caruso I et al. Multiple intra-articular treatment of rheumatoid arthritis: a randomized prospective study comparing rifamycin SV with pefloxacin. 1992 J. Int. Med. Res. pmid:1568518
Caruso I et al. Prevention of appearance of radiological lesions in early rheumatoid arthritis: a randomized, single-blind study comparing intra-articular rifamycin with auranofin. 1992 J. Int. Med. Res. pmid:1568521
Chen L et al. Cloning and preliminary characterization of lh3 gene encoding a putative acetyltransferase from a rifamycin SV-producing strain Amycolatopsis mediterranei. 2005 Biotechnol. Lett. pmid:16132864
Beltrametti F et al. Antibiotic production improvement in the rare actinomycete Planobispora rosea by selection of mutants resistant to the aminoglycosides streptomycin and gentamycin and to rifamycin. 2006 J. Ind. Microbiol. Biotechnol. pmid:16331474
Ebo DG et al. Perioperative anaphylaxis from locally applied rifamycin SV and latex. 2006 Br J Anaesth pmid:16698868
Mita S et al. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs. 2006 Drug Metab. Dispos. pmid:16760228
Dylan T et al. Hypoosmotic adaptation in Rhizobium meliloti requires beta-(1----2)-glucan. 1990 J. Bacteriol. pmid:1689716
Senturk S and Temizel M Clinical efficacy of rifamycin SV combined with oxytetracycline in the treatment of caseous lymphadenitis in sheep. 2006 Vet. Rec. pmid:16905739
Peng WT et al. Bacterial type I glutamine synthetase of the rifamycin SV producing actinomycete, Amycolatopsis mediterranei U32, is the only enzyme responsible for glutamine synthesis under physiological conditions. 2006 Acta Biochim. Biophys. Sin. (Shanghai) pmid:17151776
Yu H et al. Identification and characterization of glnA promoter and its corresponding trans-regulatory protein GlnR in the rifamycin SV producing actinomycete, Amycolatopsis mediterranei U32. 2006 Acta Biochim. Biophys. Sin. (Shanghai) pmid:17151777
Chernov AP et al. Recombinant reverse transcriptase of Rous sarcoma virus: characterization of DNA polymerase and RNAase H activities. 1991 Biomed. Sci. pmid:1717011
Alonso Lomillo MA et al. Resolution of binary mixtures of rifamycin SV and rifampicin by UV/VIS spectroscopy and partial least-squares method (PLS). 2004 Chem. Biodivers. pmid:17191911
Williams PG et al. Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. 2007 J. Nat. Prod. pmid:17253854
Necula M et al. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. 2007 J. Biol. Chem. pmid:17284452